The company raised $15 million. Silicon Valley Bank, Khosla Ventures, Drive Capital, NCT Ventures and Moonshots Capital participated in the funding round.
The funding will be used to expand sales and distribution of the company’s flagship product Queue, a patient sign-in system.
“Queue finally provides a way for patients to safely log in to healthcare, giving providers the ability to deliver a more personable level of care and returning control of patient identities back to their rightful owners — the patients themselves,” said Sean Lane, founder and CEO of CrossChx. “Queue signals a new era of patient registration, and this capital will provide the resources to fulfill demand and expand across the country.”
More articles on health IT:
IT job growth, hiring slows
90% of CIOs evaluating hybrid cloud strategy
Northgate Medical experiences internal data breach: 3 things to know
